Brief: Neuren Pharmaceuticals Posts H1 Net Income AUD 8 Mln
27/08/2024 24:19
Aug 27 (Reuters) - Neuren Pharmaceuticals H1 revenue AUD 24.3 million. * H1 net income AUD 8 million
Recent news on Neuren Pharmaceuticals
See all newsAustralia's Neuren set for weekly gain on FDA nod, drug forecast upgrade
Australia's Neuren Pharmaceuticals gains on upbeat FY trofinetide earnings outlook
Australia's Neuren Pharma rises as US FDA grants orphan tag for NNZ-2591
Strong partner sales propel Neuren Pharmaceuticals to top of Australia benchmark
Brief: Neuren Pharmaceuticals Says DAYBU Recommended For Approval In European Union